| Pregnenolone Trial for Depression in Bipolar Disorders or Recurrent Major Depressive Disorder With Substance Abuse (NCT00223197) | University of Texas Southwestern Medical Center | 2004-02-01 |
| Lamotrigine Monotherapy in Pediatric Bipolar Disorder (NCT00176228) | University of Illinois at Chicago | 2004-02-01 |
| Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder (NCT00277654) | Lindner Center of HOPE | 2004-02-01 |
| VALID : VAlproate Versus LIthium in Bipolar Disorders (NCT00264173) | Sanofi | 2004-02-01 |
| Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women? (NCT00206544) | The Alfred | 2004-01-01 |
| Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode (NCT00080314) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2004-01-01 |
| Reproductive Function and Mood in Women With Bipolar Disorder (NCT00183352) | Stanford University | 2004-01-01 |
| Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder (NCT00181727) | Massachusetts General Hospital | 2004-01-01 |
| A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders (NCT00650611) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2003-12-01 |
| Study to Determine the Effectiveness of Risperidone in Bipolar Disorder in Children and Adolescents (NCT00076115) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2003-12-01 |
| Olanzapine Versus Comparator in the Treatment of Bipolar Disorder (NCT00485680) | Eli Lilly and Company | 2003-12-01 |
| Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I Depression (NCT00485771) | Eli Lilly and Company | 2003-11-01 |
| Depression And Bipolar Disorder (NCT00274677) | GlaxoSmithKline | 2003-11-01 |
| Melancholic Symptoms in Bipolar Depression and Responsiveness to Lamotrigine (NCT02989727) | University of Saskatchewan | 2003-11-01 |
| Methylene Blue for Cognitive Dysfunction in Bipolar Disorder (NCT00214877) | Nova Scotia Health Authority | 2003-11-01 |
| Bipolar Disorder Research Study for Ages 12 and Older (NCT00211263) | Kupfer, David J., M.D. | 2003-11-01 |
| A Study of Risperidone Monotherapy in Bipolar Anxiety (NCT00167479) | University of South Florida | 2003-09-01 |
| Bipolar Study in Adults at Least 18 Years of Age (NCT00067938) | GlaxoSmithKline | 2003-08-01 |
| Evaluation of QTc Interval by Continuous Holter ECG Recording in Antipsychotic Drug-treated Patients With Schizophrenia (NCT00178958) | Northwestern University | 2003-08-01 |
| Depakote-ER for Depressive and Bipolar Depression (NCT00226343) | Cambridge Health Alliance | 2003-08-01 |
| Early Recovery Adherence Therapy for Bipolar Alcoholics (NCT00167323) | University of Pittsburgh | 2003-07-01 |
| Modifying Group Therapy for Bipolar Substance Abusers - 1 (NCT00227838) | National Institute on Drug Abuse (NIDA) | 2003-07-01 |
| Bioequivalency Study of 300 mg Lithium Carbonate Under Fed Conditions (NCT00602394) | Roxane Laboratories | 2003-05-01 |
| Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Bipolar Depression (NCT00186485) | Stanford University | 2003-05-01 |
| Acute Treatment of Bipolar II Depression (NCT00074776) | Stanford University | 2003-05-01 |
| A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder (NCT00195845) | Cambridge Health Alliance | 2003-04-01 |
| Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar (NCT00176202) | University of Illinois at Chicago | 2003-04-01 |
| A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression. (NCT00335205) | Sheba Medical Center | 2003-04-01 |
| Bioequivalency Study of 300 mg Lithium Carbonate Under Fasting Conditions (NCT00601536) | Roxane Laboratories | 2003-04-01 |
| Tamoxifen in Treatment of Acute Mania (NCT00411203) | Stanley Medical Research Institute | 2003-04-01 |
| An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and Adolescents (NCT00067262) | Abbott | 2003-03-01 |
| Risperidone Plus Mood Stabilizer in Treatment of Mixed Mania (NCT00294255) | The University of Texas Health Science Center at San Antonio | 2003-03-01 |
| Tryptophan Depletion in Acute Mania (NCT00192725) | Rambam Health Care Campus | 2003-03-01 |
| Aripiprazole for the Treatment of Mania in Children and Adolescents With Bipolar Disorder (NCT00181779) | Massachusetts General Hospital | 2003-02-01 |
| Riluzole to Treat Depression in Bipolar Disorder (NCT00054704) | National Institute of Mental Health (NIMH) | 2003-02-01 |
| Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents (NCT00057681) | Washington University School of Medicine | 2003-02-01 |
| An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder (NCT00060905) | Abbott | 2003-01-01 |
| The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States. (NCT00154323) | Novartis | 2003-01-01 |
| Bipolar Research And Innovation Network - BRAIN (NCT00201526) | Norwegian University of Science and Technology | 2003-01-01 |
| Brain Imaging in Depression (NCT00050700) | National Institute of Mental Health (NIMH) | 2002-12-16 |
| Spectroscopy in Children and Adolescents With Bipolar Disorder (NCT00181831) | Massachusetts General Hospital | 2002-12-01 |
| Quetiapine in Patients With Bipolar and Alcohol Abuse/Dependence (NCT00223249) | University of Texas Southwestern Medical Center | 2002-11-01 |
| Improving Antipsychotic Adherence Among Patients With Serious Mental Illness (NCT00057135) | US Department of Veterans Affairs | 2002-11-01 |
| Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder (NCT00050206) | Eli Lilly and Company | 2002-11-01 |
| Bioequivalency Study of 450 mg Lithium Carbonate Under Fasting Conditions (NCT00602381) | Roxane Laboratories | 2002-11-01 |
| Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression. (NCT00158990) | Hadassah Medical Organization | 2002-10-01 |
| Bioequivalency Study of 450 mg Lithium Carbonate Under Fed Conditions (NCT00601575) | Roxane Laboratories | 2002-10-01 |
| A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant Dependence (NCT00227123) | University of Texas Southwestern Medical Center | 2002-10-01 |
| Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression (NCT00060489) | AstraZeneca | 2002-09-01 |
| eCare for Moods: An Internet-based Management Program (NCT00485420) | Kaiser Permanente | 2002-09-01 |
| Treatment and Outcome of Early Onset Bipolar Disorder (NCT00048802) | Northwell Health | 2002-08-01 |
| Concerta in the Treatment of ADHD in Youth and Adults With Bipolar Disorder (NCT00181987) | Massachusetts General Hospital | 2002-08-01 |
| A Study To Investigate The Antidepressant Effect Of Lamotrigine In Patients With Bipolar Disorder Using Lithium (NCT00224510) | GlaxoSmithKline | 2002-08-01 |
| Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine (NCT00194064) | University Hospitals Cleveland Medical Center | 2002-07-01 |
| A Pilot Study of Psychodynamic Psychotherapy for Bipolar Disorder (NCT00330005) | The University of Texas Health Science Center at San Antonio | 2002-07-01 |
| Combination Therapy in Dual Diagnosis Bipolar Rapid Cycling (NCT00221975) | University Hospitals Cleveland Medical Center | 2002-07-01 |
| Family Intervention for Mental Illness and Substance Abuse (NCT00043693) | Dartmouth-Hitchcock Medical Center | 2002-04-01 |
| Clinical Trial of Felbamate for Treatment-Resistant Bipolar Depression (NCT00034229) | National Institute of Mental Health (NIMH) | 2002-04-01 |
| Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar Disorder (NCT00181922) | Massachusetts General Hospital | 2002-03-01 |
| Combination Therapy for the Treatment of Bipolar Disorders (NCT00063362) | University Hospitals Cleveland Medical Center | 2002-02-01 |
| Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder (NCT00036101) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2002-02-01 |
| Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid Cycling (NCT00254774) | AstraZeneca | 2002-01-01 |
| How Does Patients' Overall Assessment of Their Health Vary Across and Within Different Disease Groups? (NCT04359628) | Vastra Gotaland Region | 2002-01-01 |
| The Treatment of Children and Adolescents With Treatment-Resistant Depression (NCT00029640) | National Institute of Mental Health (NIMH) | 2002-01-01 |
| Clozapine for Treatment-Resistant Mania (NCT00029458) | National Institute of Mental Health (NIMH) | 2002-01-01 |
| A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder (NCT00035802) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2002-01-01 |
| Venlafaxine Versus Lamotrigine in the Treatment of Bipolar I/II Depression (NCT00188643) | University Health Network, Toronto | 2002-01-01 |
| Acupuncture as a Supplemental Treatment for Bipolar Depression (NCT00071669) | University of Texas Southwestern Medical Center | 2001-11-01 |
| Omega-3 Fatty Acids in Children and Adolescents With Bipolar Disorder (NCT00252486) | University of Rochester | 2001-11-01 |
| Indicated Prevention of Psychotic Disorders With Low-dose Lithium (NCT00202306) | Melbourne Health | 2001-11-01 |
| Lamotrigine Pregnancy Registry (LAM05) (NCT01064297) | GlaxoSmithKline | 2001-11-01 |
| Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features (NCT00202293) | Melbourne Health | 2001-10-01 |
| Topiramate Versus Placebo as add-on Treatment in Patients With Bipolar Disorder in the Outpatient Setting (NCT00237289) | Ortho-McNeil Neurologics, Inc. | 2001-10-01 |
| Clinical Trial of Pramipexole in Bipolar Depression (NCT00025792) | National Institute of Mental Health (NIMH) | 2001-10-01 |
| Health Care Management and Rehabilitation Skills Training for Treating Serious Mental Illness in Older People (NCT00169052) | Dartmouth-Hitchcock Medical Center | 2001-09-01 |
| Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder (NCT00034580) | Eli Lilly and Company | 2001-08-01 |
| A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder (NCT00035230) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2001-07-01 |
| Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study (NCT00177567) | University of Pittsburgh | 2001-07-01 |
| Evaluating the Effectiveness of Family-Focused Psychoeducation in Treating Adolescents With Bipolar Disorder (NCT00571402) | University of California, Los Angeles | 2001-07-01 |
| The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients (NCT00581009) | University of California, Irvine | 2001-05-30 |
| Pilot Study of Levetiracetam (Keppra® (Registered Trademark)) for Bipolar Illness (NCT00015769) | National Institute of Mental Health (NIMH) | 2001-04-01 |
| The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder (NCT00044187) | Eli Lilly and Company | 2001-04-01 |
| Risperidone Versus Olanzapine for Mania in Preschool Children 4 to 6 Years of Age With Bipolar Disorder (NCT00181935) | Massachusetts General Hospital | 2001-03-01 |
| Prophylactic Effect of Lamotrigine Compared With Lithium in Bipolar Disorder (NCT00226135) | University of Aarhus | 2001-03-01 |
| Lithium Versus Divalproex for Treating Pediatric Bipolar Disorder (NCT00221429) | Children's Hospital Medical Center, Cincinnati | 2001-03-01 |
| A Pharmacokinetic Study of Lithium Before and During Topiramate Dosing in Bipolar Disorder Patients (NCT00986128) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2001-03-01 |
| A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder (NCT00249236) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2001-03-01 |
| Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers (NCT00024635) | National Institute of Mental Health (NIMH) | 2001-02-02 |
| Relapse Prevention for Bipolar Type-II Disorder (NCT00044616) | University of Pennsylvania | 2001-02-01 |
| Optimizing Electroconvulsive Therapy for Depression (NCT00045916) | New York State Psychiatric Institute | 2001-02-01 |
| A Pharmacokinetic Study of Risperidone and Topiramate Administered Alone and in Combination in Patients With Bipolar Disorder or Schizoaffective Disorders (NCT00986336) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2001-02-01 |
| Effectiveness of Lithium and Valproate in Treating High-Risk Bipolar Disorder (NCT00563992) | New York State Psychiatric Institute | 2001-01-01 |
| A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder (NCT00037674) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2001-01-01 |
| Drug Treatment for Alcoholics With Bipolar Disorder (NCT00000439) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2000-10-01 |
| Child & Adolescent Bipolar Disorder Brain Imaging and Treatment Study (NCT00006177) | National Institute of Mental Health (NIMH) | 2000-08-11 |
| Omega-3 Fatty Acids in Bipolar Disorder (NCT00010868) | National Center for Complementary and Integrative Health (NCCIH) | 2000-07-01 |
| Determining the Safety and Effectiveness of Olanzapine in Children and Adolescents (NCT00183612) | Massachusetts General Hospital | 2000-05-01 |
| Bipolar Cohort Neunkirchen, Final Statement (NCT02760693) | Österreichische Gesellschaft für Bipolare Erkrankungen | 2000-05-01 |
| Study of Aripiprazole in Patients With a History of Bipolar Disorder (NCT00036348) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2000-03-01 |
| Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder (NCT00179062) | Vanderbilt University | 2000-02-01 |